InMode Ltd's share price fell by 25% in October due to the Israel-Hamas conflicts and lowered revenue guidance. The company operates in a niche market between plastic surgery and laser procedures, ...

InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

Good day, and welcome to the InMode fourth quarter and full year 2024 earnings results conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the ...

InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...

Gross margins decline — Yair Malca stated, "GAAP and non-GAAP gross margins in Q3 were 78%, down from 82% reported in Q3 2024," citing the anticipated impact of tariffs as a direct driver. Reduced ...

Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode. [Operator instructions]. After today's presentation, there will be ...